High-Dose Therapy Improves Progression-Free Survival and Survival in Relapsed Follicular Non-Hodgkin’s Lymphoma: Results From the Randomized European CUP Trial Patients and Methods: Our series ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback